Comparing Two Versions of a Hair-Loss Medication
Treatments studied
Part of Kidney & urinary clinical trials.
This study tests whether two versions of the same medication (AJU-G721 and G721R)—used to treat hair loss and urinary symptoms—work the same way in the body. Researchers will measure how much medication gets absorbed and how long it stays in your system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy male between 19 and 54 years old
- You weigh at least 50 kg (about 110 lbs) and have a normal BMI (18–30)
- You have no history of stomach or bowel surgery that could affect how your body absorbs medication
- You are not allergic to dutasteride, tamsulosin, or any similar medications
- You have not taken other medications or donated blood within the required timeframes (details discussed at screening)
- You have not participated in another drug trial in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two formulations of a prostate medication (AJU-G721 and G721R) work the same way in your body. Researchers give both versions to healthy volunteers to make sure they're equally effective and safe.
This trial tests whether two versions of a drug, AD-116A and AD-1161, are equally effective and safe in the body. Healthy adult male volunteers take the drug and have their blood levels compared.
This study tests two new experimental drugs (AD-116 and AD-1161) in healthy adult men to see how safe they are and how the body processes them. If you are a healthy man who meets the weight and age criteria, you may be able to join.
This trial compares two versions of a drug to see if they work the same in the body when taken with food. Healthy adult male volunteers are needed.
This study tests whether two different formulations of an experimental medication (AJU-C715) work the same way in your body. Researchers will give you one version and then later the other version to compare how much of the drug enters your bloodstream and how long it stays there.
This study tests an experimental medication (CKD-843) for men with male pattern baldness. It aims to see if the treatment is safe and effective for regrowing hair.
Hear when a new Moderate-to-severe Benign Prostatic Hyperplasia (BPH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.